Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase III Study of the Efficacy and Safety of Glufosfamide Compared with Fluorouracil (5-FU) in Patients with Metastatic Pancreatic Adenocarcinoma Previously Treated with Gemcitabine

Summary

The purpose of this phase III trial is to evaluate the safety and efficacy of Glufosfamide in comparison to 5-FU in patients with metastatic pancreatic cancer who have progressed on gemcitabine-based first line regimen.

General Information

NCT#: NCT01954992
Study ID: EP-GF-301
Trial Phase: Phase III

Trial Sponsor:
Therapies Used in This Trial: Fluorouracil, Leucovorin, Glufosfamide

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search